AHAfash Haleem

Afash Haleem

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Afash Haleem has a total of 60 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neck Dissection and Survival Among Head and Neck Cancer Patients Undergoing Adjuvant Immunotherapy

    by Aman M. Patel, Afash Haleem, Paul T. Cowan, Dylan F. Roden

    Background: Some studies suggest that neck dissection (ND) should be avoided in candidates for immunotherapy because lymph nodes are primary sites for immunotherapy activation. Our study investigates ND utilization and associated differences in overall survival (OS) among patients with head and neck cancer (HNC) undergoing adjuvant immunotherapy.Methods: The 2013–2018 National Cancer Database was retrospectively reviewed for patients with HNC undergoing surgery with curative intent, and adjuvant immunotherapy. Multivariable binary logistic and Cox regression models adjusted for patient demographics, clinicopathologic features, and treatment.Results: Of 1335 patients satisfying inclusion criteria, 679 (50.9%) patients underwent ND: 94 (13.8%) had pN0, 109 (16.1%) had pN1, 411 (60.5%) had pN2, 60 (8.8%) had pN3, and 5 (0.7%) had pNx classification. On multivariable binary logistic regression, academic treatment facility, cT4, and cN1–3 classification were associated with higher odds of undergoing ND (p < 0.05); salivary, sinonasal, oropharyngeal, hypopharyngeal, and laryngeal primary sites were associated with decreased odds (p < 0.05). Compared with those undergoing neck observation, patients undergoing ND had worse OS (49.4% vs. 61.5%, p < 0.001) on Kaplan–Meier but not multivariable Cox (adjusted hazard ratio [aHR] 1.00, 95% confidence interval [CI] 0.82–1.24, p = 0.968) regression. Compared with adjuvant immunotherapy alone, the addition of radiotherapy (aHR 0.64, 95% CI 0.44–0.93) and chemoradiotherapy (aHR 0.56, 95% CI 0.37–0.86) were associated with higher OS (p < 0.025).Conclusion: ND was utilized in approximately 51% of patients with HNC undergoing adjuvant immunotherapy. ND was not associated with worse OS, possibly related to the high rate of pN1–3 classification.Level of Evidence: 4


  • Open Access

    Readability of Hospital Online Patient Education Materials Across Otolaryngology Specialties

    by Akshay Warrier, Rohan P. Singh, Afash Haleem, Andrew Lee, David Mothy, Aakash Patel, Jean Anderson Eloy, Brian Manzi

    Introduction: This study evaluates the readability of online patient education materials (OPEMs) across otolaryngology subspecialties, hospital characteristics, and national otolaryngology organizations, while assessing AI alternatives.Methods: Hospitals from the US News Best ENT list were queried for OPEMs describing a chosen surgery per subspecialty; the American Academy of Otolaryngology—Head and Neck Surgery (AAO), American Laryngological Association (ALA), Ear, Nose, and Throat United Kingdom (ENTUK), and the Canadian Society of Otolaryngology—Head and Neck Surgery (CSOHNS) were similarly queried. Google was queried for the top 10 links from hospitals per procedure. Ownership (private/public), presence of respective otolaryngology fellowships, region, and median household income (zip code) were collected. Readability was assessed using seven indices and averaged: Automated Readability Index (ARI), Flesch Reading Ease Score (FRES), Flesch–Kincaid Grade Level (FKGL), Gunning Fog Readability (GFR), Simple Measure of Gobbledygook (SMOG), Coleman–Liau Readability Index (CLRI), and Linsear Write Readability Formula (LWRF). AI‐generated materials from ChatGPT were compared for readability, accuracy, content, and tone. Analyses were conducted between subspecialties, against national organizations, NIH standard, and across demographic variables.Results: Across 144 hospitals, OPEMs exceeded NIH readability standards, averaging at an 8th–12th grade level across subspecialties. In rhinology, facial plastics, and sleep medicine, hospital OPEMs had higher readability scores than ENTUK's materials (11.4 vs. 9.1, 10.4 vs. 7.2, 11.5 vs. 9.2, respectively; all p < 0.05), but lower than AAO (p = 0.005). ChatGPT‐generated materials averaged a 6.8‐grade level, demonstrating improved readability, especially with specialized prompting, compared to all hospital and organization OPEMs.Conclusion: OPEMs from all sources exceed the NIH readability standard. ENTUK serves as a benchmark for accessible language, while ChatGPT demonstrates the feasibility of producing more readable content. Otolaryngologists might consider using ChatGPT to generate patient‐friendly materials, with caution, and advocate for national‐level improvements in patient education readability.


  • In Response to The Comparative Diagnostic Capability of Large Language Models in Otolaryngology

    by Akshay Warrier, Rohan Singh, Afash Haleem, Haider Zaki, Jean A. Eloy

  • Open Access

    Primary site surgical resection in cM1 oral cavity squamous cell carcinoma

    by Aman M. Patel, Afash Haleem, Lucy Revercomb, Jason A. Brant, Karthik Rajasekaran, Lova L. Sun, Robert M. Brody, Ryan M. Carey

    Objective: To investigate primary site surgical resection and overall survival (OS) in clinically distantly metastatic (cM1) oral cavity squamous cell carcinoma (OCSCC).Methods: The 2006–2018 National Cancer Database was queried for patients presenting with cM1 OCSCC who underwent chemotherapy. Binary logistic, Kaplan–Meier, and multivariable Cox proportional hazards regression models were implemented.Results: Of 278 patients satisfying inclusion criteria, 139 (50.0%) underwent chemotherapy alone, 80 (28.8%) underwent chemoradiotherapy, 25 (9.0%) underwent surgical resection + adjuvant chemotherapy, and 34 (12.2%) underwent surgical resection + adjuvant chemoradiotherapy; 5‐year OS was 9.4%, 15.2%, 8.3%, and 23.8%, respectively (p < .001). Compared with those not undergoing surgical resection, patients undergoing surgical resection underwent radiotherapy more frequently (57.6% vs. 36.5%) but multiple‐agent chemotherapy less frequently (40.7% vs. 74.4%) (p < .005). Twenty‐one (36.2%) patients undergoing surgical resection had positive surgical margins. Academic facility (adjusted odds ratio [aOR] 3.19, 95% CI 1.54–6.62) and Charlson‐Deyo comorbidity score ≥1 (aOR 2.82, 95% CI 1.25–6.32, p < .025) were associated with increased odds of undergoing surgical resection. Compared with chemotherapy alone, chemoradiotherapy (adjusted hazard ratio [aHR] 0.56, 95% CI 0.38–0.83) and surgical resection + adjuvant chemoradiotherapy (aHR 0.37, 95% CI 0.21–0.66) were associated with higher OS (p < .005). Immunotherapy (aHR 0.48, 95% CI 0.28–0.81, p = .006) was also independently associated with higher OS.Conclusion: A minority of patients with cM1 OCSCC underwent primary site surgical resection. Despite the high rate of positive surgical margins, surgical resection + adjuvant chemoradiotherapy was associated with higher OS than chemotherapy alone, chemoradiotherapy, or surgical resection + adjuvant chemotherapy. Definitive local therapy may benefit select patients with cM1 OCSCC.Level of evidence: 4.


  • Open Access

    Association Between Modified Frailty Index and Postoperative Outcomes of Cricopharyngeal Myotomy

    by Afash Haleem, David Herz, Keshav D. Kumar, Sree R. Chinta, Dhiraj R. Sibala, Michael Hegazin, Jean Anderson Eloy

    Objective: The modified 5‐item frailty index (mFI‐5) is a comorbidity‐based risk stratification tool previously validated in patients undergoing several surgical procedures. This study investigates the association between mFI‐5 score and cricopharyngeal myotomy (CM) complications. Study Design: Retrospective database review. Setting: US hospitals. Methods: The National Surgical Quality Improvement Program database was queried for patients who underwent CM between 2005 and 2018. mFI‐5 score was determined by assigning 1 point for comorbidities including: diabetes mellitus, hypertension, congestive heart failure, chronic obstructive pulmonary disease, and dependent health status. Univariate and multivariable analyses were conducted to determine associations between mFI‐5 score and postoperative complications. Results: A total of 1075 patients undergoing CMs were queried and stratified into the following groups: mFI = 0 (n = 412 [38.3%]), mFI = 1 (n = 452 [42.0%]), and mFI ≥ 2 (n = 211 [19.6%]). Univariate analysis showed association between higher mFI‐5 scores with older age, higher American Society of Anesthesiologists Classification class, obesity, smoking, dyspnea, and systemic sepsis. Higher mFI‐5 was associated with a greater proportion of cumulative surgical complications, cumulative medical complications, pneumonia, myocardial infarction, cumulative morbidity, readmissions, unplanned readmissions, and reoperations. Multivariable analyses found associations between greater mFI‐5 score and cumulative morbidity (odds ratio [OR] = 1.95, confidence interval [CI]: 1.29‐2.96, P = .002), any surgical complication (OR = 1.80, CI: 1.15‐2.79, P = .010), readmission (OR = 1.81, CI: 1.01‐3.26, P = .047), and reoperations (OR = 1.96, CI: 1.04‐3.68, P = .037). Conclusion: Evaluating mFI‐5 can help assess the risk of postoperative complications for patients undergoing CM. Level of Evidence: Level 4.


  • Access to Sudden Hearing Loss Care at Urgent Care Centers

    by Afash Haleem, Zachary Rosenthal, Daniel J. Lee

    Objectives: To compare patient access to urgent care centers (UCCs) with a diagnosis of sudden hearing loss based on insurance.Methods: One hundred twenty‐five random UCCs in states with Medicaid expansion and 125 random UCCs in states without Medicaid expansion were contacted by a research assistant posing as a family member seeking care on behalf of a patient with a one‐week history of sudden, unilateral hearing loss. Each clinic was called once as a Medicaid patient and once as a private insurance (PI) patient for 500 total calls. Each phone encounter was evaluated for insurance acceptance and self‐pay price. Secondary outcomes included other measures of timely/accessible care. Chi‐square/McNemar's tests and independent/paired sample t‐tests were performed to determine whether there were statistically significant differences between expansion status and insurance type. Calls ended before answering questions were not included in the analysis.Results: Medicaid acceptance rate was significantly lower than PI (68.1% vs. 98.4%, p < 0.001). UCCs in Medicaid expansion states were significantly more likely to accept Medicaid (76.8% vs. 59.2%, p = 0.003). The mean wage‐adjusted self‐pay price was significantly greater in states with Medicaid expansion at $169.84 than in states without at $145.34 when called as a Medicaid patient (mean difference: $24.50, 95% Confidence Interval: $0.45–$48.54, p = 0.046). The rates of referral to an emergency department and self‐pay price nondisclosure rates were greater for Medicaid calls than for private insurance calls (8.2% vs. 0.4% and 17.4% vs. 5.8%; p < 0.001 for both).Conclusion: Medicaid patients with otologic emergencies face reduced access to care at UCCs.Level of Evidence: NA Laryngoscope, 134:5066–5072, 2024

  • Open Access

    Elective Neck Dissection in cT1‐4 N0M0 Head and Neck Basaloid Carcinoma

    by Aman M. Patel, Afash Haleem, Hassaam S. Choudhry, Robert M. Brody, Jason A. Brant, Ryan M. Carey

    Objective: To investigate the survival benefit of elective neck dissection (END) over neck observation in surgically resected cT1‐4 N0M0 head and neck basaloid carcinoma (HNBC).Study Design: Retrospective cohort study.Setting: The 2006 to 2017 hospital‐based National Cancer Database.Methods: Patients with surgically resected cT1‐4 N0M0 HNBC were selected. Linear, binary logistic, Kaplan‐Meier, and Cox proportional hazards regression models were implemented.Results: Of 857 patients satisfying inclusion criteria, the majority were male (77.0%) and white (88.1%) with disease of the oral cavity (21.5%) or oropharynx (42.9%) classified as high grade (76.9%) and cT1‐2 (72.9%). 389 (45.4%) patients underwent END. END utilization between 2006 and 2017 increased for cT1‐2 disease (33.3% vs 56.9%, R2 = .699) but remained relatively constant for cT3‐4 disease (66.7% vs 57.9%, R2 = .062). One‐hundred and fifteen (29.6%) ENDs detected occult nodal metastases (ONMs). The 5‐year overall survival (OS) of patients undergoing neck observation and END was 65.6% and 66.8%, respectively (P = .652). END was not associated with improved OS in survival analyses stratified by patient demographics, clinicopathologic features, and adjuvant therapy. Compared with surgery alone, adjuvant radiotherapy (adjusted hazard ratio: 0.74, 95% confidence interval [CI]: 0.57‐0.97, P = .031) was associated with improved OS. END (hazard ratio [HR]: 0.96, 95% CI: 0.71‐1.28, P = .770) and ONM (HR: 1.12, 95% CI: 0.78‐1.61, P = .551) were not associated with OS.Conclusion: END is performed in nearly half of patients with HNBC but is not associated with improved OS, even after stratifying survival analyses by patient demographics, clinicopathologic features, and adjuvant therapy. The rate of ONM approaching 30%, however, justifies inclusion of END in the surgical management of HNBC.


  • Top Cited Papers
    Open Access

    The Comparative Diagnostic Capability of Large Language Models in Otolaryngology

    by Akshay Warrier, Rohan Singh, Afash Haleem, Haider Zaki, Jean Anderson Eloy

    Objectives: Evaluate and compare the ability of large language models (LLMs) to diagnose various ailments in otolaryngology.Methods: We collected all 100 clinical vignettes from the second edition of Otolaryngology Cases—The University of Cincinnati Clinical Portfolio by Pensak et al. With the addition of the prompt “Provide a diagnosis given the following history,” we prompted ChatGPT‐3.5, Google Bard, and Bing‐GPT4 to provide a diagnosis for each vignette. These diagnoses were compared to the portfolio for accuracy and recorded. All queries were run in June 2023.Results: ChatGPT‐3.5 was the most accurate model (89% success rate), followed by Google Bard (82%) and Bing GPT (74%). A chi‐squared test revealed a significant difference between the three LLMs in providing correct diagnoses (p = 0.023). Of the 100 vignettes, seven require additional testing results (i.e., biopsy, non‐contrast CT) for accurate clinical diagnosis. When omitting these vignettes, the revised success rates were 95.7% for ChatGPT‐3.5, 88.17% for Google Bard, and 78.72% for Bing‐GPT4 (p = 0.002).Conclusions: ChatGPT‐3.5 offers the most accurate diagnoses when given established clinical vignettes as compared to Google Bard and Bing‐GPT4. LLMs may accurately offer assessments for common otolaryngology conditions but currently require detailed prompt information and critical supervision from clinicians. There is vast potential in the clinical applicability of LLMs; however, practitioners should be wary of possible “hallucinations” and misinformation in responses.Level of Evidence: 3 Laryngoscope, 134:3997–4002, 2024


  • Open Access

    Choice of Adjuvant Radiotherapy Facility in Major Salivary Gland Cancer

    by Aman M. Patel, Afash Haleem, Russell Maxwell, John N. Lukens, Alexander Lin, Robert M. Brody, Jason A. Brant, Ryan M. Carey

    Objective: Undergoing surgery and adjuvant radiotherapy (aRT) at the same facility has been associated with higher overall survival (OS) in head and neck squamous cell carcinoma. Our study investigates whether undergoing surgery and aRT at the same academic facility is associated with higher OS in major salivary gland cancer (MSGC).Methods: The 2006–2018 National Cancer Database was queried for patients with MSGC undergoing surgery at an academic facility and then aRT. Multivariable binary logistic and Cox proportional hazards regression models were implemented.Results: Of 2801 patients satisfying inclusion criteria, 2130 (76.0%) underwent surgery and aRT at the same academic facility. Residence in a less populated area (adjusted odds ratio [aOR] 1.69, 95% confidence interval [CI] 1.16–2.45), treatment without adjuvant chemotherapy (aOR 1.97, 95% CI 1.41–2.76), and aRT duration (aOR 1.02, 95% CI 1.01–1.04) were associated with undergoing surgery and aRT at different facilities on multivariable logistic regression adjusting for patient demographics, clinicopathologic features, and adjuvant therapy (p < 0.01). Five‐year OS was higher in patients undergoing surgery and aRT at the same academic facility (68.8% vs. 61.9%, p < 0.001). Undergoing surgery and aRT at different facilities remained associated with worse OS on multivariable Cox regression (aHR 1.41, 95% CI 1.10–1.81, p = 0.007).Conclusion: Undergoing surgery and aRT at the same academic facility is associated with higher OS in MSGC. Although undergoing surgery and aRT at the same academic facility is impractical for all patients, academic physicians should consider same‐facility treatment for complex patients who would most benefit from clear multidisciplinary communication.Level of Evidence: 4 Laryngoscope, 134:3620–3632, 2024


  • Access to Sudden Sensorineural Hearing Loss Care at Private Equity‐Owned Otolaryngology Clinics

    by Afash Haleem, Alejandro Garcia, Sophia Khan, Purvi Shakelly, Daniel J. Lee

    Objective: Characterizing access to sudden sensorineural hearing loss (SSNHL) care at private practice otolaryngology clinics of varying ownership models.Study Design: Cross‐sectional prospective review.Setting: Private practice otolaryngology clinics.Methods: We employed a Secret Shopper study design with private equity (PE) owned and non‐PE‐owned clinics within 15 miles of one another. Using a standardized script, researchers randomly called 50% of each clinic type between October 2021 and January 2022 requesting an appointment on behalf of a family member enrolled in either Medicaid or private insurance (PI) experiencing SSNHL. Access to timely care was assessed between clinic ownership and insurance type.Results: Seventy‐eight total PE‐owned otolaryngology clinics were identified across the United States. Only 40 non‐PE clinics could be matched to the PE clinics; 39 PE and 28 non‐PE clinics were called as Medicaid patients; 39 PE and 25 non‐PE clinics were called as PI patients; 48.7% of PE and 28.6% of non‐PE clinics accepted Medicaid. The mean wait time to new appointment ranged between 9.55 and 13.21 days for all insurance and ownership types but did not vary significantly (P > .480). Telehealth was significantly more likely to be offered for new Medicaid patients at non‐PE clinics compared to PE clinics (31.8% vs 0.0%, P = .001). The mean cost for an appointment was significantly greater at PE clinics than at non‐PE clinics ($291.18 vs $203.75, P = .004).Conclusions: Patients seeking SSNHL care at PE‐owned otolaryngology clinics are likely to face long wait times prior to obtaining an initial appointment and reduced telehealth options.